<HashMap><database>iProX</database><scores/><additional><omics_type>Proteomics</omics_type><submitter>Dao-Xiu Zhou</submitter><species>Oryza Sativa</species><full_dataset_link>http://www.iprox.org/page/project.html?id=IPX0010686000</full_dataset_link><submitter_email>dao-xiu.zhou@universite-paris-saclay.fr</submitter_email><submitter_affiliation>Huazhong Agricultural University</submitter_affiliation><sample_protocol></sample_protocol><repository>iProX</repository><data_protocol></data_protocol><description_synonyms>DAGA4, MGC130048, gamma sarcoglycan, DMDA, SGCG_HUMAN, DMDA1, 35 kDa dystrophin-associated glycoprotein, 35kD dystrophin-associated glycoprotein, SCARMD2, 35DAG, gamma-sarcoglycan, SG-gamma, sarcoglycan, A4, Mutations., MAM, gamma-SG, gamma (35kDa dystrophin-associated glycoprotein), SCG3, TYPE, SGCG, LGMD2C</description_synonyms><name_synonyms>Alkbh, l(1)Ab, Act5c, l(1)G0010, 2410041A17Rik, ACTG, ACTE, ACT5C, CG12051, Gene, fs(1)M34, Serpin A3, Bach, csp2, Act5, prevention, l(1)G0420, DmelCG12051, l(1)G0025, HEL-176, CG4601, Cell growth-inhibiting gene 24|25 protein, prevention and control, A, C, act5C, Abh, ABH, cyt5C, Gene Expressions, reference sample, DHO, BRWS2, CG18572, Expressions, fs(1)829, preventive measures, Act42a, anon-EST:fe2D2, abh, 1700027G07Rik, act 42A, DmelCG18572, alkbh, Ac5C, CG4027, ALKBH, ACT, Act, T11, Expression, Act-5C, Cte-II, Controlled, l(1)G0177, Gene., 42A, Controlling, preventive therapy, abh1, CPS, l(1)G0330, Actin/BAP47, CTE-II, alkB, AACT, dJ393D12.2, CTE-IIa, act, Ach1, hBACH, ACH1, LACH1, act42A, GIG25, CAD, Su(b), Alpha-1-antichymotrypsin His-Pro-less, beta-actin, AFFX-Dros-ACTIN_M_r_at, GIG24, M32055, DFNA26, Act42, actin, ACTA3, LACH, GAT, DFNA20, l(1)G0079, DmelCG4027, PYR1, prophylaxis, l(1)G0117, VSCM, act 5C, ABH1, Actin, beta-actin/Bap47, l(1)G0486, l(1)G0245, actin5C, l(1)G0009, ACTL3, control, Lach1, hABH, DRORUD, BAP47, PRC2, ACTSG, BACH, Bap47, 2700073G19Rik, Actin5C</name_synonyms></additional><is_claimable>false</is_claimable><name>MORC and ALKBH1 act antagonistically on PRC2 to control bivalent gene expression for stress tolerance</name><description>Anti-OsMORC6b IP-MS in Wild type and mutation for two replication</description><dates><publication>Thu Jan 23 00:00:00 GMT 2025</publication></dates><accession>PXD060196</accession><cross_references><TAXONOMY>4530</TAXONOMY></cross_references></HashMap>